Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: final results of a single-centre phase II trial

Br J Haematol. 2010 Jul;150(2):226-9. doi: 10.1111/j.1365-2141.2010.08179.x. Epub 2010 Apr 28.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibiotics, Antineoplastic / therapeutic use*
  • Clarithromycin / therapeutic use*
  • Conjunctival Neoplasms / drug therapy
  • Eye Neoplasms / drug therapy*
  • Feasibility Studies
  • Female
  • Humans
  • Lymphoma, B-Cell, Marginal Zone / drug therapy*
  • Male
  • Middle Aged
  • Treatment Outcome

Substances

  • Antibiotics, Antineoplastic
  • Clarithromycin